Identifying Predictors of CAR T-Cell Therapy Response

Researchers at Cleveland Clinic Research have identified distinct predictors of response or resistance to different types of chimeric antigen receptor (CAR) T-cell therapy in people with relapsed/refractory B-cell non-Hodgkin’s Lymphoma (NHL),…